Mustang Bio amends ATM equity program; up to $100M authorized, ~$8M remaining

MUSTANG BIO, INC.

Amendment No. 3 to At Market Issuance Sales Agreement dated April 14, 2023.
Total ATM offering capacity remains $100M; ~$92M already sold, ~$8M available.
Adds Instruction I.B.6 limitations based on non-affiliate market cap; removes Oppenheimer & Co. as agent.
No securities sold under Instruction I.B.6 in prior 12 months; program continues under existing registration.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.